• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用激酶抑制剂染料木黄酮和酪氨酰苯丙氨酸抑制宿主细胞中的拉萨病毒和埃博拉病毒感染。

Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.

机构信息

Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA.

出版信息

Arch Virol. 2012 Jan;157(1):121-7. doi: 10.1007/s00705-011-1115-8. Epub 2011 Sep 25.

DOI:10.1007/s00705-011-1115-8
PMID:21947546
Abstract

Arenaviruses and filoviruses are capable of causing hemorrhagic fever syndrome in humans. Limited therapeutic and/or prophylactic options are available for humans suffering from viral hemorrhagic fever. In this report, we demonstrate that pre-treatment of host cells with the kinase inhibitors genistein and tyrphostin AG1478 leads to inhibition of infection or transduction in cells infected with Ebola virus, Marburg virus, and Lassa virus. In all, the results demonstrate that a kinase inhibitor cocktail consisting of genistein and tyrphostin AG1478 is a broad-spectrum antiviral that may be used as a therapeutic or prophylactic against arenavirus and filovirus hemorrhagic fever.

摘要

沙粒病毒和丝状病毒能够引起人类出血热综合征。对于患有病毒性出血热的人类,可用的治疗和/或预防方法有限。在本报告中,我们证明用激酶抑制剂染料木黄酮和 tyrphostin AG1478 预处理宿主细胞可导致感染埃博拉病毒、马尔堡病毒和拉萨病毒的细胞的感染或转导受到抑制。总之,结果表明,由染料木黄酮和 tyrphostin AG1478 组成的激酶抑制剂混合物是一种广谱抗病毒药物,可作为抗沙粒病毒和丝状病毒出血热的治疗或预防药物。

相似文献

1
Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.用激酶抑制剂染料木黄酮和酪氨酰苯丙氨酸抑制宿主细胞中的拉萨病毒和埃博拉病毒感染。
Arch Virol. 2012 Jan;157(1):121-7. doi: 10.1007/s00705-011-1115-8. Epub 2011 Sep 25.
2
Development of treatment strategies to combat Ebola and Marburg viruses.对抗埃博拉病毒和马尔堡病毒治疗策略的研发。
Expert Rev Anti Infect Ther. 2006 Feb;4(1):67-76. doi: 10.1586/14787210.4.1.67.
3
Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.阿比多尔和其他抑制拉沙病毒和埃博拉病毒的低分子量药物。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.02185-18. Print 2019 Apr 15.
4
Development of a broad-spectrum antiviral with activity against Ebola virus.一种对埃博拉病毒具有活性的广谱抗病毒药物的研发。
Antiviral Res. 2009 Sep;83(3):245-51. doi: 10.1016/j.antiviral.2009.06.001. Epub 2009 Jun 10.
5
Identification of an antioxidant small-molecule with broad-spectrum antiviral activity.鉴定一种具有广谱抗病毒活性的抗氧化小分子。
Antiviral Res. 2012 Jan;93(1):23-9. doi: 10.1016/j.antiviral.2011.10.011. Epub 2011 Oct 18.
6
Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.三磷酸鸟苷(GTP)池耗竭不是利巴韦林对拉沙病毒发挥抗病毒作用的主要机制。
Antiviral Res. 2011 Aug;91(2):89-93. doi: 10.1016/j.antiviral.2011.05.006. Epub 2011 May 17.
7
Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems.使用微型基因组和重组病毒报告系统鉴定出的拉沙病毒和埃博拉病毒抑制剂。
Antiviral Res. 2016 Dec;136:9-18. doi: 10.1016/j.antiviral.2016.10.007. Epub 2016 Oct 19.
8
Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus.靶向拉沙病毒保守RNA末端的小干扰RNA的广谱抗病毒活性
Antimicrob Agents Chemother. 2007 Jun;51(6):2215-8. doi: 10.1128/AAC.01368-06. Epub 2007 Mar 19.
9
[Viral hemorrhagic fever--Ebola hemorrhagic fever, Marburg disease and Lassa fever].[病毒性出血热——埃博拉出血热、马尔堡病和拉沙热]
Rinsho Byori. 1998 Jul;46(7):651-5.
10
Emerging intracellular receptors for hemorrhagic fever viruses.出血热病毒的新兴细胞内受体。
Trends Microbiol. 2015 Jul;23(7):392-400. doi: 10.1016/j.tim.2015.04.006. Epub 2015 May 21.

引用本文的文献

1
AG1478 Elicits a Novel Anti-Influenza Function via an EGFR-Independent, GBF1-Dependent Pathway.AG1478 通过一种非 EGFR 依赖、GBF1 依赖的途径发挥新型抗流感功能。
Int J Mol Sci. 2022 May 16;23(10):5557. doi: 10.3390/ijms23105557.
2
Modulating Neurological Complications of Emerging Infectious Diseases: Mechanistic Approaches to Candidate Phytochemicals.调节新发传染病的神经并发症:候选植物化学物质的作用机制研究方法
Front Pharmacol. 2021 Oct 26;12:742146. doi: 10.3389/fphar.2021.742146. eCollection 2021.
3
Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
埃博拉病毒触发受体酪氨酸激酶依赖性信号转导,以促进病毒颗粒向有利于进入的细胞内隔室的输送。
PLoS Pathog. 2021 Jan 29;17(1):e1009275. doi: 10.1371/journal.ppat.1009275. eCollection 2021 Jan.
4
Commonalities Between COVID-19 and Radiation Injury.新型冠状病毒肺炎与辐射损伤之间的共性
Radiat Res. 2021 Jan 1;195(1):1-24. doi: 10.1667/RADE-20-00188.1.
5
The upshot of Polyphenolic compounds on immunity amid COVID-19 pandemic and other emerging communicable diseases: An appraisal.多酚类化合物在新冠疫情及其他新出现的传染病中对免疫力的影响:评估
Nat Prod Bioprospect. 2020 Dec;10(6):411-429. doi: 10.1007/s13659-020-00271-z. Epub 2020 Oct 15.
6
Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS.确定对抗COVID-19的新药物治疗方法:一种使用iLINCS的基于特征的方法。
Res Sq. 2020 Apr 30:rs.3.rs-25643. doi: 10.21203/rs.3.rs-25643/v1.
7
Current status of small molecule drug development for Ebola virus and other filoviruses.埃博拉病毒和其他丝状病毒小分子药物研发的现状。
Curr Opin Virol. 2019 Apr;35:42-56. doi: 10.1016/j.coviro.2019.03.001. Epub 2019 Apr 16.
8
Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors.引起出血热的沙粒病毒:致命病原体和强效免疫抑制剂。
Front Immunol. 2019 Mar 13;10:372. doi: 10.3389/fimmu.2019.00372. eCollection 2019.
9
Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.设计和开发针对埃博拉病毒的疫苗、药物和疗法的进展。
Front Immunol. 2018 Aug 10;9:1803. doi: 10.3389/fimmu.2018.01803. eCollection 2018.
10
Flavonoids: promising natural compounds against viral infections.黄酮类化合物:对抗病毒感染的有前景的天然化合物。
Arch Virol. 2017 Sep;162(9):2539-2551. doi: 10.1007/s00705-017-3417-y. Epub 2017 May 25.